These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24679050)

  • 1. Purification of bovine serum paraoxonase and its immobilization on Eupergit C 250 L by covalent attachment.
    Sayın M; Guler OO
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):69-74. PubMed ID: 24679050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics.
    Sinan S; Kockar F; Arslan O
    Biochimie; 2006 May; 88(5):565-74. PubMed ID: 16600468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of Holstein bull semen paraoxonase 1 (PON1) by hydrophobic interaction chromatography and investigation of its inhibition kinetics by heavy metals.
    Dedeoğlu N; Arslan M; Erzengin M
    Biol Trace Elem Res; 2014 Apr; 158(1):29-35. PubMed ID: 24563030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative purification method for human serum paraoxonase 1 and its interaction with methidathion.
    Gençer N; Yavuz E
    Arch Physiol Biochem; 2017 Jul; 123(3):159-164. PubMed ID: 28276711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of paraoxonase 1 (PON1) from Swiss Black, Holstein, and Montofon bovines.
    Erzengin M; Demir D; Arslan M; Sinan S
    Appl Biochem Biotechnol; 2014 Aug; 173(7):1597-606. PubMed ID: 24907040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification, characterization, and investigation of in vitro inhibition by metals of paraoxonase from different sheep breeds.
    Erol K; Gençer N; Arslan M; Arslan O
    Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):125-30. PubMed ID: 22947096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition effect of some dihydroxy coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Erzengin M; Basaran I; Cakir U; Aybey A; Sinan S
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1540-8. PubMed ID: 22971832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of heavy metal effects on immobilized paraoxanase by glutaraldehyde.
    Bilen Ç; Beyaztaş S; Arslan O; Güler ÖÖ
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):440-6. PubMed ID: 22233542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases.
    Ekinci D; Beydemir S
    Eur J Pharmacol; 2009 Sep; 617(1-3):84-9. PubMed ID: 19577563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative purification method for human serum paraoxonase 1 and its interactions with sulfonamides.
    Ekinci D; Sentürk M; Beydemir S; Küfrevioğlu OI; Supuran CT
    Chem Biol Drug Des; 2010 Dec; 76(6):552-8. PubMed ID: 21040495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of human serum paraoxonase-1 with some respiratory drugs.
    Gökçe B; Sarıoğlu N; Gençer N; Arslan O
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22407. PubMed ID: 31581362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes.
    Bayrak A; Bayrak T; Demirpençe E; Kılınç K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):49-55. PubMed ID: 21123122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum.
    Işgör MM; Beydemir S
    Eur J Pharmacol; 2010 Oct; 645(1-3):135-42. PubMed ID: 20670621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
    Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
    Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of thirty-eight cardiac drugs on human serum paraoxonase.
    Argan O; Cikrikci K; Uslu H; Gencer N
    Chem Biol Drug Des; 2022 Jul; 100(1):80-89. PubMed ID: 35395139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 1-bound magnetic nanoparticles: preparation and characterizations.
    Kockar F; Beyaz S; Sinan S; Köçkar H; Demir D; Eryilmaz S; Tanrisever T; Arslan O
    J Nanosci Nanotechnol; 2010 Nov; 10(11):7554-9. PubMed ID: 21137981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.
    Karataş MO; Uslu H; Alıcı B; Gökçe B; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1386-91. PubMed ID: 26887799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative purification method for human serum paraoxonase 1 and its interactions with anabolic compounds.
    Demir D; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016; 31(2):247-52. PubMed ID: 25792501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase 1 as a major bioactivating hydrolase for olmesartan medoxomil in human blood circulation: molecular identification and contribution to plasma metabolism.
    Ishizuka T; Fujimori I; Nishida A; Sakurai H; Yoshigae Y; Nakahara K; Kurihara A; Ikeda T; Izumi T
    Drug Metab Dispos; 2012 Feb; 40(2):374-80. PubMed ID: 22086979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.